Company Overview and News


Add RMD
to your dashboard

Headline News

Can ResMed (RMD) Maintain Balanced Growth in Q1 Earnings?

2017-10-16 zacks
ResMed (RMD - Free Report) is slated to report first-quarter fiscal 2018 results, after markets close on Oct 26. Last quarter, the company delivered a positive earnings surprise of 2.7%. with average earnings beat of 1.7% for three of the trailing four quarters. Let's see how things are shaping up for this announcement. (37-0)

Daily Technical Summary Reports on Medical Equipment Stocks -- Invacare, ResMed, Stryker, and Zimmer Biomet

2017-10-13 prnewswire
If you want a Stock Review on IVC, RMD, SYK, or ZBH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. For today, DailyStockTracker.com scans four equities to see how they have fared at the close of the last trading session: Invacare Corp. (NYSE: IVC), ResMed Inc. (NYSE: RMD), Stryker Corp. (NYSE: SYK), and Zimmer Biomet Holdings Inc. (NYSE: ZBH). Medical Appliances and Equipment companies primarily offer equipment and devices, which are designed for diagnosis, monitoring, and treatment of patients in healthcare systems worldwide. (29-0)

Key Technologies Gathering Real-time Data to Improve Sleep Quality

2017-10-12 prnewswire
SANTA CLARA, Calif., Oct. 12, 2017 /PRNewswire/ -- The current sleep tech market is flooded with devices, sensors, wearables, and mobile applications that collect sleep data along with other physiological and lifestyle parameters. However, from a consumer standpoint, data collection is irrelevant if there is no action or direction that positively impacts sleep quality. Consumers today want the "so what" of their sleep and lifestyle data so they can make better choices and take control of their health. (3-0)

Corporate News Blog - German Court Stays Infringement Proceedings Against Fisher & Paykel In ResMed Patent Infringement Case

2017-10-09 accesswire
LONDON, UK / ACCESSWIRE / October 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ResMed Inc. (NYSE: RMD), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=RMD. The Company announced on October 06, 2017, provided an update in the patent infringement case against Fisher & Paykel Healthcare Corp. (17-0)

Global Homecare Medical Equipment Market Expected to Reach $35,183 Million by 2023 - Allied Market Research

2017-10-05 prnewswire
According to a new report published by Allied Market Research, titled, "Homecare Medical Market Report by Functionality: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global homecare medical equipment market accounted for $21,912 million in 2016, and is estimated to reach $35,183 million by 2023, registering a CAGR of 7.1% from 2017 to 2023. Therapeutic equipment was the highest contributor in the home medical equipment market in 2016; however, mobility assist & patient support equipment segment is expected to witness the highest growth rate during the forecast period. (51-0)

Breathe Deeply And Buy ResMed

2017-10-02 seekingalpha
ResMed I thought was a great BUY in the $60 per share range, and a good buy at $73. It still is for investors after topping an all-time high price. (65-0)

UPDATE 1-German court suspends Resmed's complaint against NZ's Fisher & Paykel

2017-09-28 reuters
WELLINGTON, Sept 29 (Reuters) - A German court has suspended health appliance firm ResMed Inc’s intellectual property proceedings against New Zealand’s Fisher & Paykel Healthcare Corp, according to a statement from Fisher & Paykel. (1-0)

3 Dividend Healthcare Stocks

2017-08-16 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Earnings Review and Free Research Report: ResMed Adjusted Diluted EPS Increased 4%

2017-08-16 accesswire
LONDON, UK / ACCESSWIRE / August 16, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on ResMed Inc. (NYSE: RMD), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=RMD, following the Company's reporting of its financial results on August 01, 2017, for the fourth quarter fiscal 2017. The Company's revenue increased 7.3% on a y-o-y basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:

Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators

2017-08-11 accesswire
LONDON, UK / ACCESSWIRE / August 11, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Varian Medical Systems, Inc. (NYSE: VAR), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=VAR. The Company announced on August 09, 2017, that it has signed an agreement with Bionix® Radiation Therapy to become the non-exclusive distributor of Bionix®'s brachytherapy applicators. (0-1)

HealthSouth Invades Big Pharma Duet To Place Atop 'Safer' Dividend Healthcare Pack For Gains In August

2017-08-11 seekingalpha
Top "safer" dividend Healthcare dog GSK's 20% net gain was nearly half the combined estimated amounts for OMI, per analyst targets 8/4/17.

Worldwide Sleep Apnea Device Market 2017-2023 - Technological Advances in Diagnostics and Therapeutic Devices

2017-08-10 prnewswire
The "Worldwide Sleep Apnea Device Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering.

ResMed: Buy On The Dip

2017-08-04 seekingalpha
ResMed the sleep device and software pioneer reports notably successful Q4 earnings and on that the stock price slipped 9%--Huh? It's a good time to buy.

ResMed Tops Expectations but Falls Anyway

2017-08-03 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

ResMed Announces Results For The Fourth Quarter Of Fiscal Year 2017

2017-08-02 devicespace
SAN DIEGO, Aug. 1, 2017 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended June 30, 2017. Revenue for the quarter was $556.7 million, a 7 percent increase compared to the same period of the prior year. Excluding the contribution from the Brightree business acquired in April 2016, revenue for the quarter was $520.5 million, a 6 percent increase.   

ResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track

2017-08-02 zacks
ResMed Inc. (RMD - Free Report) announced fourth-quarter fiscal 2017 adjusted earnings per share (EPS) of 77 cents, up 4.1% from the prior-year quarter level. Earnings also beat the Zacks Consensus Estimate by 2 cents.

ResMed (RMD) Q4 2017 Results - Earnings Call Transcript

2017-08-02 seekingalpha
Welcome to the Q4 Fiscal Year 2017 ResMed, Inc. Earnings Conference Call. My name is Mariama, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. Please note that this conference is being recorded.

Medical Products Earnings Due on Aug 1: IDXX, RMD

2017-07-31 zacks
We are at the second half of the second-quarter earnings season and per our Earnings Preview, till Jul 28, around 286 S&P 500 members (68.8% of the Index’s total market cap) have reported their quarterly numbers.

Respiratory Devices Market Worth US$22.1 Billion by 2025: Increasing Prevalence of COPD Propels Growth

2017-07-31 prnewswire
Transparency Market Research (TMR) in one of its recent reports observes the global respiratory devices market to be fragmented with the presence of several small and medium-size companies that operate in niche market segments. In order to sustain the competition, leading players are striving to leverage new technologies to upgrade their existing products as well as to expand their product portfolios.

Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

2017-07-21 zacks
ResMed Inc. (RMD - Free Report) is slated to report fourth-quarter fiscal 2017 results, after markets close on Aug 1.

Here's Why You Should Add ResMed to Your Portfolio Now

2017-07-12 zacks
California-based ResMed, Inc. (RMD - Free Report) has been on a healthy growth trajectory of late. The company is a leading global manufacturer and distributor of generators, masks and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders.

ResMed Sees Potential in SDB Market, Eyes Global Growth

2017-07-07 zacks
On Jul 6, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD - Free Report) . The company is a global manufacturer and distributor of generators, masks and related accessories for treatment of sleep-disordered breathing (SDB) and other respiratory disorders. At present, the company’s line of products includes airflow generators, diagnostic products, mask systems, headgear and other accessories.

Global Respiratory Care Devices Market 2017-2023 - Therapeutics, Monitoring, Diagnostics, and Consumables

2017-06-29 prnewswire
Research and Markets has announced the addition of the "Global Respiratory Care Devices Market - Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering.

ResMed (RMD) at 52-Week High: What's Driving the Stock?

2017-06-20 zacks
Share price of ResMed Inc. (RMD - Free Report) scaled a new 52-week high of $79.22 on Jun 19, eventually closing a bit lower at $78.91. The company has gained 28.1% over the past six months, ahead of the S&P 500’s 7.6% gain. The stock has a market cap of $11.19 billion.

Project $1M: Outperformance Continues, But I'm Still Concerned

2017-06-05 seekingalpha
While I've been pleased with the progress of the portfolio, I'm not sure how much longer the outperformance can continue.